Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Vaneck Biotech ETF (BBH)

Vaneck Biotech ETF (BBH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Fund Family Van Eck Associates
  • Assets Under Management 386,649,200
  • Shares Outstanding, K 1,990
  • 60-Month Beta 0.79
  • Price/Earnings ttm 22.13
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend 1.252 on 12/23/24
  • Management Fee 0.35%
  • INDUSTRY GROUPING:

    ETFs - Biotech

Options Overview Details

View History
  • Implied Volatility 23.53% (-0.84%)
  • Historical Volatility 21.44%
  • IV Percentile 82%
  • IV Rank 21.97%
  • IV High 47.88% on 04/10/25
  • IV Low 16.67% on 09/11/25
  • Expected Move (DTE 9) 0.00 (0.00%)
  • Put/Call Vol Ratio 0.00
  • Today's Volume 2
  • Volume Avg (30-Day) 5
  • Put/Call OI Ratio 0.99
  • Today's Open Interest 270
  • Open Int (30-Day) 258
  • Expected Range 194.30 to 194.30

Price Performance

See More
Period Period Low Period High Performance
1-Month
186.47 +4.20%
on 01/20/26
202.91 -4.25%
on 01/27/26
+1.01 (+0.52%)
since 01/09/26
3-Month
182.92 +6.22%
on 11/11/25
202.91 -4.25%
on 01/27/26
+11.90 (+6.52%)
since 11/10/25
52-Week
135.34 +43.56%
on 04/09/25
202.91 -4.25%
on 01/27/26
+32.69 (+20.23%)
since 02/10/25

Most Recent Stories

More News
VanEck Announces Year-End Distributions for VanEck Equity ETFs

VanEck announced today the following 2025 annual distributions per share for its VanEck ® equity exchange-traded funds. Distributions Per Share for the...

BJK : 38.21 (+0.19%)
AFK : 28.73 (+0.10%)
CRAK : 44.06 (-0.70%)
EVX : 42.07 (+0.50%)
RTH : 261.22 (-0.91%)
BBH : 194.30 (-1.91%)
BUZZ : 31.62 (-1.50%)
SMHX : 40.32 (-0.75%)
ESPO : 97.88 (+1.34%)
GPZ : 25.35 (+0.54%)
SMOG : 141.66 (+0.28%)
VNM : 18.08 (+0.19%)
Are Wall Street Analysts Predicting Vertex Pharmaceuticals Stock Will Climb or Sink?

Vertex Pharmaceuticals has lagged behind the broader market over the past year, and Wall Street analysts are cautiously optimistic about the stock’s future.

$SPX : 6,941.81 (-0.33%)
VRTX : 463.48 (-1.57%)
BBH : 194.30 (-1.91%)
Is Wall Street Bullish or Bearish on Vertex Pharmaceuticals Stock?

Vertex Pharmaceuticals has outperformed the broader market over the past year, and analysts are moderately optimistic about the stock’s prospects.

$SPX : 6,941.81 (-0.33%)
VRTX : 463.48 (-1.57%)
BBH : 194.30 (-1.91%)
Are Wall Street Analysts Bullish on Vertex Pharmaceuticals Stock?

Vertex Pharmaceuticals has outperformed the broader market in 2024 but Wall Street analysts remain cautiously bullish about the stock's potential.

$SPX : 6,941.81 (-0.33%)
VRTX : 463.48 (-1.57%)
BBH : 194.30 (-1.91%)
Is Wall Street Bullish or Bearish on Bio-Techne Stock?

Bio-Techne has underperformed the broader market this year, but Wall Street analysts are optimistic about the stock’s prospects.

TECH : 64.80 (-1.04%)
$SPX : 6,941.81 (-0.33%)
BBH : 194.30 (-1.91%)
Biogen Earnings Preview: What to Expect

Biogen is expected to release its fiscal second-quarter earnings next month, and analysts project a single-digit profit dip.

$SPX : 6,941.81 (-0.33%)
BBH : 194.30 (-1.91%)
BIIB : 188.99 (-2.49%)
Moderna's Quarterly Earnings Preview: What You Need to Know

Moderna is expected to release its fiscal second-quarter earnings next month, and analysts project a narrower loss.

$SPX : 6,941.81 (-0.33%)
BBH : 194.30 (-1.91%)
MRNA : 41.99 (+0.11%)
What You Need to Know Ahead of Amgen's Earnings Release

Amgen is expected to release its fiscal second-quarter earnings next month, and analysts project a single-digit profit dip.

$SPX : 6,941.81 (-0.33%)
BBH : 194.30 (-1.91%)
AMGN : 364.65 (-2.97%)
Is Wall Street Bullish or Bearish on Moderna Stock?

Moderna has outperformed many of its peers and the broader market YTD, but Wall Street analysts are cautiously optimistic about the stock's prospects.

$SPX : 6,941.81 (-0.33%)
BBH : 194.30 (-1.91%)
MRNA : 41.99 (+0.11%)
What Are Wall Street Analysts' Target Price for Amgen Stock?

Amgen has outperformed the broader market and many of its peers over the past year, but Wall Street analysts believe it has limited upside left.

$SPX : 6,941.81 (-0.33%)
BBH : 194.30 (-1.91%)
AMGN : 364.65 (-2.97%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

Relative Strength just crossed below 50%. The market is indicating support for a bearish trend.

See More Share

Fund Summary

The VanEck Vectors Biotech ETF seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS US Listed Biotech 25 Index, which is intended to track the overall performance of companies involved in the development and production, marketing and sales of...

See More

Key Turning Points

3rd Resistance Point 201.02
2nd Resistance Point 199.67
1st Resistance Point 196.99
Last Price 194.30
1st Support Level 192.95
2nd Support Level 191.61
3rd Support Level 188.92

See More

52-Week High 202.91
Last Price 194.30
Fibonacci 61.8% 177.10
Fibonacci 50% 169.13
Fibonacci 38.2% 161.15
52-Week Low 135.34

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar